OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Pharma industry loses on Medicare price ...

Drugmakers generate most of their sales in the U.S. The Pharmaceutical Research and Manufacturers of America - the industry's ...

A closer look at the top biotechnology and pharmaceutical companies in the 2025 IndustryWeek 500. The pharmaceutical industry ...

And pharmaceutical companies spend big on lobbying in Washington — more than any other industry in 2017 — helping to assure victories like the 2003 Medicare Part D legislation which banned the ...

Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...

This piece is the first in a series exploring the foundational players in the U.S. healthcare system: payers, providers, ...

The European pharmaceutical industry said Tuesday that it remained concerned a EU-US trade deal reached at the weekend does not provide certainty for critical sector. The EFPIA trade association for ...

The European Union's trade deal with the United States could cost the pharmaceutical industry between $13 billion and $19 ...

The threat comes as Trump's administration pressures pharmaceutical companies to lower drug prices for Americans.

There are also signs pointing to the onset of pharma Industry 4.0, which is characterized by the integration of connectivity, AI and robotics to enable systems that operate with little or no human ...

The pharmaceutical sector, a beacon of innovation, stands tall in Europe's economic landscape. Yet even a robust industry is not immune to financial challenges.